35 results
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
may prevent us from hiring those individuals or subject us to suit from their former employers. In addition, since we are independently
6-K
EX-99
BLRX
BioLineRx Ltd.
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
-readiness activities. We recently completed hiring an experienced sales force, and have substantially advanced supply chain, market access and medical
20-F/A
EX-4.40
opq3horhqbvkd
31 May 16
Annual report (foreign) (amended)
12:00am
20-F/A
683wc5r2ahg pj
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B5
3u672 c7976i5e0na
6 Mar 15
Prospectus supplement for primary offering
12:00am
424B5
k2jz s3mxbytzx12b
5 Mar 15
Prospectus supplement for primary offering
12:00am
6-K
EX-99.3
fdr4z8nmm2w64
5 Mar 15
Current report (foreign)
12:00am
424B2
u812aeoa9aume
13 Jun 14
Prospectus for primary offering
12:00am
F-3
ejrze
30 May 14
Shelf registration (foreign)
12:00am